Cabot insider plans 2,779-share sale after $7.9M stock sale

CABOT CORP (CBT) is the issuer for a planned insider sale reported under Rule 144 for the account of Sean D. Keohane.

Rhea-AI Filing Summary

CABOT CORP (CBT) is the issuer for a planned insider sale reported under Rule 144 for the account of Sean D. Keohane. The notice covers 2,779 shares of common stock, expected to be sold through Fidelity Brokerage Services LLC on 08/24/2026 on the NYSE following a stock option exercise paid in cash.

The filing also reports that during the prior three months, Sean D. Keohane sold 91,923 shares of CABOT CORP common stock on 08/07/2026 for an aggregate sale price of $7,942,634.39.

Key Figures

Shares proposed for sale: 2,779 shares of common stock Acquisition method: Stock Option Exercise Shares sold in prior 3 months: 91,923 shares +2 more

5 metrics

Shares proposed for sale 2,779 shares of common stock Planned Rule 144 sale on or about 08/24/2026 via Fidelity on NYSE

Acquisition method Stock Option Exercise Shares to be sold on 08/24/2026 acquired on 08/24/2026 via option exercise for cash

Shares sold in prior 3 months 91,923 shares Sale of CABOT CORP common stock on 08/07/2026

Aggregate sale price (prior sale) $7,942,634.39 Aggregate sale price for 91,923 shares sold on 08/07/2026

Planned sale date 08/24/2026 Expected date of sale for the 2,779 shares under Rule 144

Key Terms

Rule 144, Stock Option Exercise, aggregate sale price, attorney-in-fact

4 terms

Rule 144 regulatory

"See the definition of "person" in paragraph (a) of Rule 144."

Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.

Stock Option Exercise financial

"Common | 08/24/2026 | Stock Option Exercise | Issuer"

A stock option exercise is the act of using a previously granted right to buy shares of a company's stock at a specific, predetermined price by paying that price and receiving the shares. It matters to investors because exercising changes who owns the shares (which can dilute existing ownership), can trigger taxable events and shift potential gains or losses, and affects voting power and the company’s outstanding share count—like turning a voucher into an actual product that becomes part of circulating supply.

aggregate sale price financial

"| 08/07/2026 | 91923 | 7942634.39"

attorney-in-fact regulatory

"as attorney-in-fact for Sean D. Keohane"

An attorney-in-fact is the person or entity given legal authority through a power of attorney to act on behalf of another for specific tasks, such as signing documents, voting shares, or handling transactions. For investors, this matters because it lets a trusted representative make timely decisions or complete paperwork when the owner cannot, much like handing keys to someone to run errands on your behalf—so checks on scope and limits of that authority are important.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction in CABOT CORP (CBT) is disclosed in this Form 144?

The Form 144 discloses a proposed sale by Sean D. Keohane of 2,779 shares of CABOT CORP common stock on or about 08/24/2026 on the NYSE, following acquisition of the shares through a stock option exercise paid in cash.

How many CABOT CORP (CBT) shares has Sean D. Keohane sold recently?

The filing states that on 08/07/2026, Sean D. Keohane sold 91,923 shares of CABOT CORP common stock, with an aggregate sale price of $7,942,634.39, during the three months preceding the new proposed sale.

What is the size of the new CABOT CORP (CBT) sale proposed under Rule 144?

The proposed sale under Rule 144 covers 2,779 shares of CABOT CORP common stock. These shares are to be sold through Fidelity Brokerage Services LLC, with the expected sale date listed as 08/24/2026 on the NYSE.

How were the CABOT CORP (CBT) shares to be sold on 08/24/2026 acquired?

The 2,779 shares of CABOT CORP common stock to be sold on or about 08/24/2026 were acquired on that same date through a stock option exercise, with the form noting that the consideration for the acquisition was cash.

Who is filing the CABOT CORP (CBT) Form 144 and who signs it?

The securities are to be sold for the account of Sean D. Keohane. The Form 144 is signed on 08/24/2026 by /s/ Gary Redman, acting as a duly authorized representative of Fidelity Brokerage Services LLC and attorney-in-fact for Sean D. Keohane.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 08/24/2026 - 05:11 PM Accepted by SEC EDGAR 08/24/2026 - 05:10 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001435737
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	CABOT CORP
SEC File Number	001-05667
Address of Issuer	TWO SEAPORT LANE SUITE 1400 BOSTON MASSACHUSETTS 02210
Phone	6173450100
Name of Person for Whose Account the Securities are To Be Sold	Keohane Sean D
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer
Relationship to Issuer	Director

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	2779	237604.50	51631007	08/24/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	08/24/2026	Stock Option Exercise	Issuer			2779	08/24/2026	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Sean D. Keohane Two Seaport Lane Suite 1400 Boston MA 02210-2019	Common	08/07/2026	91923	7942634.39

144: Remarks and Signature

Remarks
Date of Notice	08/24/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Gary Redman, as a duly authorized representative of Fidelity Brokerage Services LLC, as attorney-in-fact for Sean D. Keohane
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)